Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity
- Conditions
- Immunity
- Interventions
- Dietary Supplement: Cauliflower Mushroom extractDietary Supplement: Placebo
- Registration Number
- NCT01736787
- Lead Sponsor
- Chonbuk National University Hospital
- Brief Summary
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cauliflower Mushroom extract on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-4, IL-10, IFN- γ, TNF-α), and CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT), and monitored their blood pressure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Males and females 30-65 years old
- Weight within ±30% of ideal body weight
- Able to give informed consent
- WBC concentration below 3000 ㎕
- Allergic or hypersensitive to any of the ingredients in the test products
- Diagnosed of gastrointestinal disease such as Immune-related diseases, severe hepatic, renal failure, and diabetes
- History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
- History of alcohol or substance abuse
- Participation in any other clinical trials within past 2 months
- Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- Pregnant or lactating women etc.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cauliflower Mushroom extract Cauliflower Mushroom extract - Placebo Placebo -
- Primary Outcome Measures
Name Time Method Changes in Cytotoxicity 12 weeks Cytotoxicity was measured in study visit 1(0 week) and visit 3(12 week). cytotoxicity was measured by NK cell activity. Cytotoxicity (%) = (experimental release - spontaneous release) / (maximum release - spontaneous release) x 100
Changes in Cytokine (IL-4, IL-10, IFN- γ, TNF-α) 12 weeks Cytokine (IL-4, IL-10, IFN- γ, TNF-α) was measured in study visit 1(0 week) and visit 3(12 week).
- Secondary Outcome Measures
Name Time Method Changes in CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT) 12 weeks CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT) was measured in study visit 1(0 week) and visit 3(12 week).
Trial Locations
- Locations (1)
Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
🇰🇷Jeonju, Jeollabuk-do, Korea, Republic of